Additionally, the same trend was observed in the population of CD8+ T cells within the tumor and the infiltrating T cells, where the T cells in the YH29407 and aPD-1 combination treatment group were higher than those in the control and all other groups (Figure 4B). Here, CD8A is linked to neoplasm.